Showing results (171-180 of 12,169) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|January 1, 1992
End-organ disease in hypertension: what have we learned?E Grossman, F H MesserliJournal of Cardiovascular Pharmacology|January 1, 1992
Kinetics of angiotensin-converting enzyme inhibitors in renal failureD A SicaJournal of Cardiovascular Pharmacology|January 1, 1992
Left ventricular hypertrophy and performance: therapeutic options among the angiotensin-converting enzyme inhibitorsR M ZusmanJournal of Cardiovascular Pharmacology|January 1, 1992
Introduction: the metabolic cardiovascular syndromeH ArnesenJournal of Cardiovascular Pharmacology|January 1, 1992
Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal womenI Os, G NordbyJournal of Cardiovascular Pharmacology|January 1, 1992
The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertensionS E Kjeldsen, M Rostrup, A Moan, et al.Journal of Cardiovascular Pharmacology|November 14, 2021
Current Perspectives of the Use of Sodium-Glucose Transport-2 Inhibitors for Patients With Heart Failure and Chronic Kidney DiseaseEtty Vider, Ravit Sapir, Eli Mosseri, et al.Journal of Cardiovascular Pharmacology|December 3, 2021
Renin-Angiotensin System Blocker in COVID-19. A Single Center StudyRiya Job, Mohamed Abdul Qader, Pedro Torres, et al.Journal of Cardiovascular Pharmacology|December 3, 2021
Pinitol Protects Against Ox-Low-Density Lipoprotein-Induced Endothelial Inflammation and Monocytes AttachmentXiao-Hong Chen, Yu Tan, ShuQin Yu, et al.Journal of Cardiovascular Pharmacology|March 12, 2019
Real-Life Indications to Sacubitril/Valsartan Treatment in Patients With Chronic Systolic Heart FailureGiuseppe Pinto, Lara Tondi, Marco Gemma, et al.Pageof 1,217